There are 1.5 million children with autism in America, and the United States is the largest market for autism treatment programs. This is a long-term growth market.

Meal replacements such as shakes and nutrition bars have long been a popular DIY option for American dieters. Retail non-prescription appetite suppressants such as fat burners and other diet pills have also been popular. Both products are easy to obtain, inexpensive, and carry no significant side effects.

The $38 billion U.S. commercial weight loss market is 15% larger than in 2020, but has had to pivot to adjust to huge competition from the popular GLP-1 drugs.

At no other time in the U.S. weight loss market history has one product so dominated the market as have the new GLP-1 weight loss drugs. American dieters have flocked to them, shunning commercial weight loss programs such as Weight Watchers, Medifast, as well as retail and MLM meal replacements.

Outpatient physical therapy is in demand, as the U.S. population ages. A stable reimbursement environment, private equity investment, and the popularity of PT as an alternative to opioids for pain management all contribute to a positive outlook through 2030.

Business brokers form a growing $1.8 billion U.S. market boosted by the large number of businesses now being sold by retiring Baby Boomers, Millennials, and others. The market is 80% untapped as only 20% of the businesses sold are sold by business brokers.

An estimated 70 million Americans have insomnia, and 39 million suffer from obstructive sleep apnea (OSA), mostly undiagnosed. As obesity rates remain high, this problem is not likely to dissipate any time soon. Therefore, there is ample room for future growth of CPAP devices and sleep studies, performed at home or in specialized clinics.

Tattoos and body art in the U.S. have soared in popularity lately, especially amongst Millennials and Gen Z, fueling an industry comprised of 11,600 tattoo studios. The industry, which also includes tattoo removal services, is estimated to be worth $4.5 billion, and is growing strongly.

Telehealth soared during the pandemic in 2020 as consumers stayed home and communicated with their physicians via Zoom video calls and by phone, email and chat. The number of telehealth companies exploded. Then, in 2021-2023, as demand for the GLP-1 weight loss medications took off, many of these telehealth providers added weight loss plans based on access to these drugs, plus support.

The total U.S. weight loss market is estimated to have grown to a historic peak of $90 billion in 2023, boosted by soaring sales of the popular prescription GLP-1 weight loss drugs. This is a major paradigm shift toward medical programs, and a major challenge for competing commercial diet companies, which lost $1+ billion in revenues since 2022.